Literature DB >> 15804180

Differential cytosolic delivery and presentation of antigen by listeriolysin O-liposomes to macrophages and dendritic cells.

Ethan M Stier1, Manas Mandal, Kyung-Dall Lee.   

Abstract

Delivery of antigenic protein to the cytosol of antigen-presenting cells (APCs), such as macrophages (MPhi) and dendritic cells (DCs), is required for an efficient CD8 T-cell-mediated immune response. We have previously shown that co-encapsulation of antigenic protein inside pH-sensitive liposomes with listeriolysin O (LLO), a pore-forming protein of Listeria monocytogenes, generates efficient major histocompatibility complex class I (MHC I)-restricted immune responses both in vitro and in vivo. In this study, we sought to analyze the relative efficiency of LLO-mediated cytosolic delivery of liposomal antigen in two important APCs, macrophages and dendritic cells, by examining the sequential steps involved in antigen presentation to T-cells in cultured mouse bone marrow-derived MPhis (BMMPhis) and DCs (BMDCs). BMMPhis overall presented liposomal antigen better than BMDCs at a given concentration of liposomal antigen incubated with cells, and the trend was also observed after the presentation was normalized by the uptake of antigen. When soluble antigen was directly introduced into the cytosol, however, BMDCs presented the antigen more efficiently than BMMPhis. In addition, when the APCs were externally loaded with the antigenic peptide of the protein, BMDCs displayed a higher level of cell surface MHC I-peptide complexes and presented the peptide more efficiently than BMMPhis. These results combined together suggest that LLO-mediated release of liposomal antigen from the endosomal/lysosomal compartment may be more pronounced in BMMPhis than in BMDCs, and further implicates differential activity of LLO and varying efficiency of LLO-mediated endosomal escape in different antigen-presenting cell types.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15804180     DOI: 10.1021/mp049896v

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  16 in total

1.  Encapsulating immunostimulatory CpG oligonucleotides in listeriolysin O-liposomes promotes a Th1-type response and CTL activity.

Authors:  Chasity D Andrews; Myung-Sook Huh; Kathryn Patton; Debbie Higgins; Gary Van Nest; Gary Ott; Kyung-Dall Lee
Journal:  Mol Pharm       Date:  2012-04-06       Impact factor: 4.939

Review 2.  Applications of biological pores in nanomedicine, sensing, and nanoelectronics.

Authors:  Sheereen Majd; Erik C Yusko; Yazan N Billeh; Michael X Macrae; Jerry Yang; Michael Mayer
Journal:  Curr Opin Biotechnol       Date:  2010-06-18       Impact factor: 9.740

3.  In vivo targeting of dendritic cells for activation of cellular immunity using vaccine carriers based on pH-responsive microparticles.

Authors:  Young Jik Kwon; Edward James; Nilabh Shastri; Jean M J Fréchet
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-12       Impact factor: 11.205

4.  Cytosolic delivery of liposomally targeted proteins induced by photochemical internalization.

Authors:  Marjan M Fretz; Anders Høgset; Gerben A Koning; Wim Jiskoot; Gert Storm
Journal:  Pharm Res       Date:  2007-05-31       Impact factor: 4.200

5.  Galactosylated LDL nanoparticles: a novel targeting delivery system to deliver antigen to macrophages and enhance antigen specific T cell responses.

Authors:  Fang Wu; Sherry A Wuensch; Mitra Azadniv; Mohammad R Ebrahimkhani; I Nicholas Crispe
Journal:  Mol Pharm       Date:  2009 Sep-Oct       Impact factor: 4.939

6.  Conjugation of lipid and CpG-containing oligonucleotide yields an efficient method for liposome incorporation.

Authors:  Chasity D Andrews; Chester J Provoda; Gary Ott; Kyung-Dall Lee
Journal:  Bioconjug Chem       Date:  2011-06-15       Impact factor: 4.774

7.  Nondominant CD8 T cells are active players in the vaccine-induced antitumor immune response.

Authors:  Jennifer N Uram; Chelsea M Black; Emilee Flynn; Lanqing Huang; Todd D Armstrong; Elizabeth M Jaffee
Journal:  J Immunol       Date:  2011-02-23       Impact factor: 5.422

8.  Evaluation of the safety and adjuvant effect of a detoxified listeriolysin O mutant on the humoral response to dengue virus antigens.

Authors:  K G Hernández-Flores; A L Calderón-Garcidueñas; G Mellado-Sánchez; R Ruiz-Ramos; L A Sánchez-Vargas; P Thomas-Dupont; I Y Izaguirre-Hernández; J Téllez-Sosa; J Martínez-Barnetche; L Wood; Y Paterson; L Cedillo-Barrón; O López-Franco; H Vivanco-Cid
Journal:  Clin Exp Immunol       Date:  2017-01-19       Impact factor: 4.330

9.  Improvement of RG1-VLP vaccine performance in BALB/c mice by substitution of alhydrogel with the next generation polyphosphazene adjuvant PCEP.

Authors:  Sarah M Valencia; Athina Zacharia; Alexander Marin; Rebecca L Matthews; Chia-Kuei Wu; Breana Myers; Chelsea Sanders; Simone Difilippantonio; Reinhard Kirnbauer; Richard B Roden; Ligia A Pinto; Robert H Shoemaker; Alexander K Andrianov; Jason D Marshall
Journal:  Hum Vaccin Immunother       Date:  2021-02-11       Impact factor: 3.452

10.  Probiotics and gastrointestinal disease: successes, problems and future prospects.

Authors:  Eamonn P Culligan; Colin Hill; Roy D Sleator
Journal:  Gut Pathog       Date:  2009-11-23       Impact factor: 4.181

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.